Geneos Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.3K Sell
216
-235
-52% -$51.4K ﹤0.01% 1602
2025
Q1
$101K Buy
451
+243
+117% +$54.4K ﹤0.01% 1568
2024
Q4
$68.1K Hold
208
﹤0.01% 1197
2024
Q3
$62.4K Buy
208
+32
+18% +$9.61K ﹤0.01% 1118
2024
Q2
$58K Hold
176
﹤0.01% 1021
2024
Q1
$69.6K Hold
176
﹤0.01% 959
2023
Q4
$62K Hold
176
﹤0.01% 994
2023
Q3
$66K Hold
176
﹤0.01% 997
2023
Q2
$67.3K Sell
176
-125
-42% -$47.8K ﹤0.01% 988
2023
Q1
$104K Hold
301
0.01% 833
2022
Q4
$70.8K Hold
301
﹤0.01% 930
2022
Q3
$74K Sell
301
-1,516
-83% -$373K 0.01% 894
2022
Q2
$559K Hold
1,817
0.03% 464
2022
Q1
$746K Hold
1,817
0.03% 438
2021
Q4
$852K Sell
1,817
-82
-4% -$38.5K 0.03% 444
2021
Q3
$797K Sell
1,899
-50
-3% -$21K 0.03% 448
2021
Q2
$712K Sell
1,949
-296
-13% -$108K 0.03% 462
2021
Q1
$737K Sell
2,245
-39
-2% -$12.8K 0.02% 524
2020
Q4
$550K Buy
2,284
+319
+16% +$76.8K 0.02% 515
2020
Q3
$529K Buy
1,965
+383
+24% +$103K 0.03% 415
2020
Q2
$351K Hold
1,582
0.02% 498
2020
Q1
$223K Hold
1,582
0.02% 580
2019
Q4
$238K Hold
1,582
0.01% 636
2019
Q3
$222K Hold
1,582
0.01% 622
2019
Q2
$197K Hold
1,582
0.01% 669
2019
Q1
$174K Hold
1,582
0.01% 691
2018
Q4
$152K Hold
1,582
0.01% 687
2018
Q3
$195K Hold
1,582
0.01% 653
2018
Q2
$157K Hold
1,582
0.01% 628
2018
Q1
$139K Hold
1,582
0.01% 644
2017
Q4
$156K Hold
1,582
0.01% 607
2017
Q3
$152K Hold
1,582
0.02% 593
2017
Q2
$149K Hold
1,582
0.02% 578
2017
Q1
$129K Hold
1,582
0.01% 591
2016
Q4
$134K Hold
1,582
0.02% 544
2016
Q3
$117K Buy
1,582
+82
+5% +$6.06K 0.02% 563
2016
Q2
$114K Hold
1,500
0.02% 559
2016
Q1
$105K Buy
+1,500
New +$105K 0.02% 565